Zenotech Laboratories Limited
ZENOTECH.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.63B
Close$
$43.60
1.2% upside
Current Fair Value
1.2% upsideUndervalued by 1.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.63 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.18 |
| Beta | 0.28 |
| Outstanding Shares | 65,071,429 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -105.05 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zenotech Laboratories Limited
264 employees
CEO: Sachin Laxmanappa Gavandare Zenotech Laboratories Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of various medical products. Notably, its production activities include granulocyte-colony stimulating factor (G...